Close

News

Artificial Intelligence – A Game-Changer For NHS Healthcare

The fact is that generative AI happens to have the capacity where it can actually go on to transform the way patients have an interaction with the NHS when consuming healthcare. If in case the challenges that are faced while...

Waiting List Challenges Growing Concern For NHS, England

Commenting on the monthly performance statistics of the NHS in England, the Assistant Director of Policy at the Health Foundation, Tim Gardner, said that although the winter pressure has gone on to ease, the present data goes on to...

Baptist Health, Caregility Expand Partnership to Enhance Patient Care

Baptist Health and Caregility are expanded partnership aimed at enhancing patient care across the Arkansas-based healthcare organization. Baptist Health will enhance its bedside care teams by increasing its usage of Caregility intelligent telehealth devices to more than 700 bedsides system-wide,...

OSF HealthCare collaborates with DELFI for lung cancer screening

SF HealthCare has partnered with DELFI Diagnostics to implement the FirstLook Lung test, aiming to boost lung cancer screening rates. This initiative aligns with the Biden Cancer Moonshot’s objective to increase access to cancer screening. The DELFI Diagnostics’ FirstLook Lung test,...

Exactech launches new knee replacement software ExactechGPS

Exactech has launched ExactechGPS, a new software designed to improve total knee replacement surgery with patient-centric planning and alignment. This advancement integrates ligament-driven balancing technology, enhancing the company’s Newton Knee balancing technique, which allows for simultaneous planning of femur and...

Brixton Biosciences secures $33m to develop osteoarthritis pain platform

Brixton Biosciences, a spin-out from Massachusetts General Brigham and a clinical stage life sciences company developing novel therapies for chronic and acute pain announced that it closed a Series B funding round of $33M. The round was led by...

PhotoPharmics brings in first PD patients for phototherapy device trial

PhotoPharmics has enrolled the first patients with Parkinson’s disease (PD) in a study aimed at demonstrating the efficacy of its phototherapy device in improving symptoms of the disease. The first 25 patients enrolled are part of a 300-strong target for...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read